drug
calcipotriene
Marketedupdated 3mo agoby Prasco LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4indications
investigational
Psoriasis
all catalysts(25)
approval · 25
Dec 29, 1993
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jul 13, 1995
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jul 22, 1996
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Aug 15, 1996
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 20, 1997
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Dec 18, 1998
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 11, 1999
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 11, 1999
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jul 7, 1999
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jan 11, 2000
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jan 11, 2000
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 23, 2001
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 23, 2001
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Apr 28, 2005
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Apr 28, 2005
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Sep 26, 2007
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Sep 26, 2007
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Nov 21, 2013
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jan 14, 2014
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jun 12, 2014
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Jul 3, 2014
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 11, 2015
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Mar 11, 2015
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Oct 3, 2025
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Oct 3, 2025
approval
DOVONEX (CALCIPOTRIENE) — FDA approval
calcipotriene
→
Trials studying calcipotriene
- phase2Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
- phase3LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
- phase3Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 7, 2028
~1.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- May 7, 2028formulationUS 82635801.7y
- May 26, 2026formulationUS 8629128
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that